Author

O. Gires

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Libl· 1 shared F. Simon· 1 shared G. Kranz· 1 shared H. Schinke· 1 shared H. Yuanyu· 1 shared I. Ilik· 1 shared J. Hoermann· 1 shared K. Gaertner· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. Libl

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The nuclear speckles protein SRRM2 is a new therapeutic target molecule on the surface of cancer cells

M. Kellner, J. Hoermann, S. Fackler, H. Yuanyu, L. Lin, I. Ilik, T. Aktas, R. Feederle, S. M. Hauck, O. Gires, K. Gaertner, L. Lietao, R. Zeidler

The paper identifies SRRM2 as a surface-exposed cancer target and shows its utility in CAR-T cell therapy.

bioRxiv · Apr 26, 2024 · PreprintCancer Biology

Partial epithelial-to-mesenchymal transition is prognostic and associates with Slug in head and neck cancer

H. Schinke, M. Pan, M. Akyol, G. Kranz, D. Libl, F. Simon, M. Canis, P. Baumeister, O. Gires

The paper identifies a partial epithelial-to-mesenchymal transition (p-EMT) signature in HNSCC linked to poor prognosis and Slug expression, showing its clinical relevance and mechanistic role in therapy resistance.

bioRxiv · Oct 20, 2020 · PreprintCancer Biology